微创胸骨保留主动脉瓣置换联合升主动脉置换与单纯主动脉瓣置换的结果比较
本研究回顾性比较了2019至2024年796例微创胸骨保留主动脉瓣置换患者,其中624例单纯AVR,172例联合近端升主动脉和/或半弓置换。结论认为联合手术不显著增加短期并发症或死亡风险。
要点
- 微创胸骨保留AVR联合升主动脉置换的手术时间显著延长,但短期卒中率和转化率无显著差异。
核心结论
- 微创胸骨保留AVR联合升主动脉和/或半弓置换与单纯AVR相比,手术时间延长,但不显著增加短期并发症或死亡风险。
研究设计与样本
- 回顾性分析2019至2024年796例患者,比较624例单纯AVR与172例AVR联合近端升主动脉和/或半弓置换(其中108例半弓置换伴循环停止)。
临床怎么用
- 在微创胸骨保留AVR中,可同期行升主动脉和/或半弓置换而不显著增加短期并发症或死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to compare the outcomes of minimally invasive aortic valve replacement (AVR) with or without concomitant ascending aortic and hemiarch replacement. The focus was on assessing the impact of additional ascending aortic procedures on postoperative morbidity and mortality in the context of minimally invasive sternal-sparing surgery. METHODS: In a retrospective analysis of 796 patients from 2019 to 2024, 2 groups were compared: 624 patients underwent isolated AVR, and 172 underwent combined AVR with proximal ascending aortic and/or hemiarch replacement (AVR+Asc). Among the latter group, 108 patients had a hemiarch replacement with circulatory arrest. The study examined postoperative outcomes, including mortality, stroke rates, and 30-day readmission rates. RESULTS: The median age of the patients was 64 (IQR, 58-72) years, and 25% of the patients were female. Operative times were longer in the AVR+Asc than AVR group, with increased cardiopulmonary bypass (152 vs 93 minutes; P < .001) and cross-clamp (124 vs 69 minutes; P < .001) times. However, no major significant differences were observed in conversion (0.6% vs 0.2%; P = .4), stroke (0.2% vs 0.0%; P = .2) rates between the groups. Intensive care unit stay durations were similar (26 vs 27 hours; P = .2), although hospital stays were longer for the AVR+Asc group (4 vs 3 days; P < .001). The in-hospital mortality rates were slightly higher in the AVR+Asc group (1.2% vs 0.0%; Fisher's P = .046) but did not differ significantly from the isolated AVR group at 5 years (log-rank P = .14). CONCLUSIONS: Minimally invasive, sternal-sparing AVR+Asc is associated with longer operative times but does not significantly increase short-term morbidity or mortality compared with isolated AVR. These findings suggest that additional ascending aortic procedures during minimally invasive AVR can be performed without substantially increasing postoperative risks.
引用
- Lamelas J, Alnajar A. Comparing Outcomes of Sternal-Sparing Aortic Valve Replacement With and Without Concomitant Ascending Aortic Replacement. Ann Thorac Surg. 2025. PMID: 40645361. doi:10.1016/j.athoracsur.2025.06.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。